In a previous post we covered the April 14, 2020 statement from the SEC’s Division of Investment Management encouraging registered funds to assess and, as appropriate, update their prospectus risk disclosures in light of the COVID-19 pandemic. Now, Dalia Blass, Director of the Division, has joined with the Chairman of the SEC, the PCAOB Chairman and others at the SEC to release a joint public statement discussing how Emerging Market Investments Entail Significant Disclosure, Financial Reporting and Other Risks; Remedies are Limited (the “Statement”).
The Statement highlights challenges that the SEC and the PCAOB continue to observe in emerging markets. Corporate data flow in emerging markets can be significantly limited for political and other reasons, which can impact the valuation and risk assessment of emerging market companies. The Statement reminds investment advisers and registered and private funds of their disclosure obligations generally, and posits key disclosure and other considerations around emerging market investments.
Continue Reading Emerging Markets Risks: Disclosure Considerations for Funds and Advisers